187 related articles for article (PubMed ID: 35482122)
1. Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer.
Tollens F; Baltzer PAT; Dietzel M; Schnitzer ML; Schwarze V; Kunz WG; Rink J; Rübenthaler J; Froelich MF; Schönberg SO; Kaiser CG
Eur Radiol; 2022 Nov; 32(11):7409-7419. PubMed ID: 35482122
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer-How Low-Cost Must MRI Be?
Tollens F; Baltzer PAT; Dietzel M; Rübenthaler J; Froelich MF; Kaiser CG
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808955
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue.
Geuzinge HA; Bakker MF; Heijnsdijk EAM; van Ravesteyn NT; Veldhuis WB; Pijnappel RM; de Lange SV; Emaus MJ; Mann RM; Monninkhof EM; de Koekkoek-Doll PK; van Gils CH; de Koning HJ;
J Natl Cancer Inst; 2021 Nov; 113(11):1476-1483. PubMed ID: 34585249
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program.
Wang J; Greuter MJW; Vermeulen KM; Brokken FB; Dorrius MD; Lu W; de Bock GH
Breast; 2022 Feb; 61():58-65. PubMed ID: 34915447
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of supplemental breast cancer screening modalities to mammography or digital breast tomosynthesis in women with heterogeneously and extremely dense breasts and average or intermediate breast cancer risk in US healthcare.
Blankenburg M; Sánchez-Collado I; Soyemi BO; Åkerborg Ö; Caleyachetty A; Harris J; Morris E; Newstead G; Lobig F
J Med Econ; 2023; 26(1):850-861. PubMed ID: 37278659
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
[TBL] [Abstract][Full Text] [Related]
7. Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis.
Shih YT; Dong W; Xu Y; Etzioni R; Shen Y
Ann Intern Med; 2021 May; 174(5):602-612. PubMed ID: 33556275
[TBL] [Abstract][Full Text] [Related]
8. Impact of specificity on cost-effectiveness of screening women at high risk of breast cancer with magnetic resonance imaging, mammography and ultrasound.
Kaiser CG; Dietzel M; Vag T; Rübenthaler J; Froelich MF; Tollens F
Eur J Radiol; 2021 Apr; 137():109576. PubMed ID: 33556759
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
Moore SG; Shenoy PJ; Fanucchi L; Tumeh JW; Flowers CR
BMC Health Serv Res; 2009 Jan; 9():9. PubMed ID: 19144138
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of MR-mammography vs. conventional mammography in screening patients at intermediate risk of breast cancer - A model-based economic evaluation.
Kaiser CG; Dietzel M; Vag T; Froelich MF
Eur J Radiol; 2021 Mar; 136():109355. PubMed ID: 33214003
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of MR-Mammography in Breast Cancer Screening of Women With Extremely Dense Breasts After Two Rounds of Screening.
Tollens F; Baltzer PAT; Dietzel M; Schnitzer ML; Kunz WG; Rink J; Rübenthaler J; Froelich MF; Kaiser CG
Front Oncol; 2021; 11():724543. PubMed ID: 34568052
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of MR-mammography as a solitary imaging technique in women with dense breasts: an economic evaluation of the prospective TK-Study.
Froelich MF; Kaiser CG
Eur Radiol; 2021 Feb; 31(2):967-974. PubMed ID: 32856166
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
Comstock CE; Gatsonis C; Newstead GM; Snyder BS; Gareen IF; Bergin JT; Rahbar H; Sung JS; Jacobs C; Harvey JA; Nicholson MH; Ward RC; Holt J; Prather A; Miller KD; Schnall MD; Kuhl CK
JAMA; 2020 Feb; 323(8):746-756. PubMed ID: 32096852
[TBL] [Abstract][Full Text] [Related]
15. Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis.
Phi XA; Greuter MJW; Obdeijn IM; Oosterwijk JC; Feenstra TL; Houssami N; de Bock GH
Breast; 2019 Jun; 45():82-88. PubMed ID: 30904701
[TBL] [Abstract][Full Text] [Related]
16. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
Mango VL; Goel A; Mema E; Kwak E; Ha R
J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.
Pataky R; Armstrong L; Chia S; Coldman AJ; Kim-Sing C; McGillivray B; Scott J; Wilson CM; Peacock S
BMC Cancer; 2013 Jul; 13():339. PubMed ID: 23837641
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of abbreviated magnetic resonance imaging (AB-MRI) screening in women with a personal history (PH) of breast cancer.
An YY; Kim SH; Kang BJ; Suh YJ; Jeon YW
PLoS One; 2020; 15(3):e0230347. PubMed ID: 32163500
[TBL] [Abstract][Full Text] [Related]
19. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
